We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRUE
3376
DELISTED
TrueCar
TRUE
$16K ﹤0.01%
6,235
-14,568
-70% -$30.3K
UPLD icon
3377
Upland Software
UPLD
$15.7M
$16K ﹤0.01%
221
+3
+1% +$224
USA icon
3378
Liberty All-Star Equity Fund
USA
$1.87B
$16K ﹤0.01%
2,825
+2,029
+255% +$12.1K
USPH icon
3379
US Physical Therapy
USPH
$1.21B
$16K ﹤0.01%
199
-1,417
-88% -$119K
VCEL icon
3380
Vericel Corp
VCEL
$2.26B
$16K ﹤0.01%
608
-11,648
-95% -$277K
VTV icon
3381
Vanguard Morningstar Value ETF
VTV
$194B
$16K ﹤0.01%
117
+14
+14% +$1.93K
VTYX
3382
DELISTED
Ventyx Biosciences
VTYX
$16K ﹤0.01%
506
-1,490
-75% -$44.1K
WBX
3383
Wallbox
WBX
$75.2M
$16K ﹤0.01%
+230
New +$26.1K
WCC
3384
WESCO International
WCC
$17.6B
$16K ﹤0.01%
124
-5,227
-98% -$658K
WEAV icon
3385
Weave Communications
WEAV
$437M
$16K ﹤0.01%
3,564
+728
+26% +$3.57K
XHR
3386
Xenia Hotels & Resorts
XHR
$1.77B
$16K ﹤0.01%
1,194
-9,125
-88% -$136K
ZIP icon
3387
ZipRecruiter
ZIP
$386M
$16K ﹤0.01%
1,005
-15,958
-94% -$265K
ASTH icon
3388
Astrana Health
ASTH
$2.02B
$16K ﹤0.01%
523
-7,191
-93% -$231K
BERY
3389
DELISTED
Berry Global Group, Inc.
BERY
$16K ﹤0.01%
286
-4,630
-94% -$227K
NGM
3390
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$16K ﹤0.01%
3,052
-2,622
-46% -$16.4K
AVTA
3391
DELISTED
Avantax, Inc. Common Stock
AVTA
$16K ﹤0.01%
628
-8,848
-93% -$203K
RETA
3392
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$16K ﹤0.01%
433
-2,448
-85% -$84.2K
DCP
3393
DELISTED
DCP Midstream, LP
DCP
$16K ﹤0.01%
427
+233
+120% +$9.02K
EMKR
3394
DELISTED
Emcore Corp
EMKR
$16K ﹤0.01%
1,643
+916
+126% +$13.1K
AAT
3395
American Assets Trust
AAT
$1.4B
$15K ﹤0.01%
595
-3,143
-84% -$85.1K
ADVM
3396
DELISTED
Adverum Biotechnologies
ADVM
$15K ﹤0.01%
2,514
+127
+5% +$963
AEIS icon
3397
Advanced Energy
AEIS
$13.2B
$15K ﹤0.01%
170
-5,635
-97% -$473K
APRE icon
3398
Aprea Therapeutics
APRE
$8.42M
$15K ﹤0.01%
2,379
+1,263
+113% +$13.3K
AVPT icon
3399
AvePoint
AVPT
$2.85B
$15K ﹤0.01%
3,603
-10,986
-75% -$47K
BALY icon
3400
Bally's
BALY
$685M
$15K ﹤0.01%
753
-1,693
-69% -$37.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.